175 related articles for article (PubMed ID: 722244)
1. Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins.
Schreiber RD; Müller-Eberhard HJ
J Exp Med; 1978 Dec; 148(6):1722-7. PubMed ID: 722244
[TBL] [Abstract][Full Text] [Related]
2. Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.
Fearon DT; Austen KF
J Exp Med; 1977 Jul; 146(1):22-33. PubMed ID: 559720
[TBL] [Abstract][Full Text] [Related]
3. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
Medicus RG; Götze O; Müller-Eberhard HJ
J Exp Med; 1976 Oct; 144(4):1076-93. PubMed ID: 978134
[TBL] [Abstract][Full Text] [Related]
4. Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody.
Patrick Sissons JG; Schreiber RD; Perrin LH; Cooper NR; Müller-Eberhard HJ; Oldstone MB
J Exp Med; 1979 Sep; 150(3):445-54. PubMed ID: 479760
[TBL] [Abstract][Full Text] [Related]
5. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
Pangburn MK; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1978 May; 75(5):2416-20. PubMed ID: 276881
[TBL] [Abstract][Full Text] [Related]
6. Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
Schreiber RD; Pangburn MK; Lesavre PH; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3948-52. PubMed ID: 279011
[TBL] [Abstract][Full Text] [Related]
7. Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement.
Schreiber RD; Pangburn MK; Medicus RG; Müller-Eberhard HJ
Clin Immunol Immunopathol; 1980 Mar; 15(3):384-96. PubMed ID: 6899978
[No Abstract] [Full Text] [Related]
8. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
Hänsch GM; Hammer CH; Mayer MM; Shin ML
J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
[TBL] [Abstract][Full Text] [Related]
9. C56 formation in the reaction mixture of isolated complement components through the classical complement pathway.
Kitamura H; Tsuboi M; Nagaki K
Int Arch Allergy Appl Immunol; 1985; 78(1):101-7. PubMed ID: 4030125
[TBL] [Abstract][Full Text] [Related]
10. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.
Fearon DT
Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1971-5. PubMed ID: 273923
[TBL] [Abstract][Full Text] [Related]
11. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
12. Hemolysis of normal human erythrocytes by autologous serum complement.
Kitamura H; Nagano A; Kitano E
Int Arch Allergy Immunol; 1993; 100(3):209-14. PubMed ID: 8453307
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the alternative pathway of complement by pH.
Fishelson Z; Horstmann RD; Müller-Eberhard HJ
J Immunol; 1987 May; 138(10):3392-5. PubMed ID: 2952717
[TBL] [Abstract][Full Text] [Related]
14. Purification and quantitation of the components of the alternative complement pathway.
Minta JO; Gee AP
Methods Enzymol; 1983; 93():375-408. PubMed ID: 6223199
[No Abstract] [Full Text] [Related]
15. Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.
Fearon DT; Austen KF
Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1683-7. PubMed ID: 266208
[TBL] [Abstract][Full Text] [Related]
16. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
[TBL] [Abstract][Full Text] [Related]
17. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
Densen P; McRill CM; Ross SC
J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
[TBL] [Abstract][Full Text] [Related]
18. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
Kitamura H; Tsuboi M; Nagaki K
Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
[TBL] [Abstract][Full Text] [Related]
19. Binding of activated properdin to untreated erythrocytes: a new function of activated properdin.
Konno T; Hirai H; Tamura N
Immunology; 1978 Feb; 34(2):207-15. PubMed ID: 627406
[TBL] [Abstract][Full Text] [Related]
20. The cytolytic C5b-9 complement complex: feedback inhibition of complement activation.
Bhakdi S; Maillet F; Muhly M; Kazatchkine MD
Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1912-6. PubMed ID: 3162317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
